Long-Term Efficacy of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: Data from a Pivotal Phase 3 Clinical Trial. J of Skin [Internet]. 2018 Feb. 23 [cited 2025 Apr. 18];2(S1):S9. Available from: https://skin.dermsquared.com/skin/article/view/253